Vertex Pharmaceuticals Incorporated VRTX
At closeNov 11, 2026, 5:25 PM EST
After hours · Nov 11, 5:25 PM ET
- YTD
- +20.66%
- 1 year
- +27.45%
VRTX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
3,193,800,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 3,193,800,000 | 3,984,100,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -790,300,000 | -4,127,200,000 | -123.68% |
| FY 2023 | 2023-12-31 | 3,336,900,000 | -588,300,000 | -14.99% |
| FY 2022 | 2022-12-31 | 3,925,200,000 | 1,516,700,000 | 62.97% |
| FY 2021 | 2021-12-31 | 2,408,500,000 | -585,200,000 | -19.55% |
| FY 2020 | 2020-12-31 | 2,993,700,000 | 1,499,800,000 | 100.39% |
| FY 2019 | 2019-12-31 | 1,493,900,000 | 319,063,000 | 27.16% |
| FY 2018 | 2018-12-31 | 1,174,837,000 | 429,316,000 | 57.59% |
| FY 2017 | 2017-12-31 | 745,521,000 | 565,981,000 | 315.24% |
| FY 2016 | 2016-12-31 | 179,540,000 | 590,274,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -410,734,000 | 213,579,000 | Not meaningful |
| FY 2014 | 2014-12-31 | -624,313,000 | -512,254,000 | Not meaningful |
| FY 2013 | 2013-12-31 | -112,059,000 | -308,760,000 | -156.97% |
| FY 2012 | 2012-12-31 | 196,701,000 | 87,561,000 | 80.23% |
| FY 2011 | 2011-12-31 | 109,140,000 | 782,636,000 | Not meaningful |
| FY 2010 | 2010-12-31 | -673,496,000 | -222,414,000 | Not meaningful |
| FY 2009 | 2009-12-31 | -451,082,000 | -192,420,000 | Not meaningful |
| FY 2008 | 2008-12-31 | -258,662,000 | 26,229,000 | Not meaningful |
| FY 2007 | 2007-12-31 | -284,891,000 | -229,999,000 | Not meaningful |
| FY 2006 | 2006-12-31 | -54,892,000 | 134,121,000 | Not meaningful |
| FY 2005 | 2005-12-31 | -189,013,000 | -34,358,000 | Not meaningful |
| FY 2004 | 2004-12-31 | -154,655,000 | 30,319,000 | Not meaningful |
| FY 2003 | 2003-12-31 | -184,974,000 | -66,560,000 | Not meaningful |
| FY 2002 | 2002-12-31 | -118,414,000 | -61,976,000 | Not meaningful |
| FY 2001 | 2001-12-31 | -56,438,000 | -25,697,000 | Not meaningful |
| FY 2000 | 2000-12-31 | -30,741,000 | 7,558,000 | Not meaningful |
| FY 1999 | 1999-12-31 | -38,299,000 | 566,000 | Not meaningful |
| FY 1998 | 1998-12-31 | -38,865,000 | -23,539,000 | Not meaningful |
| FY 1997 | 1997-12-31 | -15,326,000 | 28,910,000 | Not meaningful |
| FY 1996 | 1996-12-31 | -44,236,000 | -25,208,000 | Not meaningful |
| FY 1995 | 1995-12-31 | -19,028,000 | -114,000 | Not meaningful |
| FY 1994 | 1994-12-31 | -18,914,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-05T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.